bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
aurobindo pharma limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
bupropion hydrochloride 75 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
59651-874
Product ID
59651-874_8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075491
Listing Expiration
2026-12-31
Marketing Start
2024-04-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59651874
Hyphenated Format
59651-874
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA075491 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 75 mg/1
Packaging
- 100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["6563b923-269f-40c3-b992-cbacdfca6e16"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)", "package_ndc": "59651-874-01", "marketing_start_date": "20240425"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "59651-874_8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "59651-874", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA075491", "marketing_category": "ANDA", "marketing_start_date": "20240425", "listing_expiration_date": "20261231"}